Webinar-Pharmaceutical Pollution vs. Environmental Health
Webinar-Pharmaceutical pollution vs. Environmental health 28th March 2018, 9:00 GMT+0 28th March 2018, 16:00 GMT+0 The continuously growing market for both human and veterinary medicine highlights heavy reliance on pharmaceuticals. The increasing demand for pharmaceuticals, however, can lead to increased amounts entering the environment, either in the form of the original active pharmaceutical ingredients (APIs) or as metabolites and transformation products. There is increasing evidence that even low concentrations of pharmaceuticals can pose environmental risks (e.g., antimicrobial agents, pharmaceuticals with endocrine-disrupting effects, some antiparasitics and some anti-inflammatory drugs, X-ray contrast media). Although several studies report very low risks for human health at the concentrations measured in the environment, long-term effects on humans as a result of chronic exposure to pharmaceuticals has not been yet explored. Pharmaceuticals can be released into the environment at all stages in their life cycle - from manufacturing to disposal. However, there are a number of gaps and inefficiencies in currently pharmaceuticals management practices at all stages of this life cycle. At the international level, there is no legislative mean in place to address the issue of pharmaceuticals in the environment. While at the EU level this issue is mainly covered in legislation relating to veterinary medicinal products but is less recognised in legislation dealing with medicinal products for human use. In this webinar, you will learn from recent research on the presence of pharmaceuticals in the environment and its impact and also about your role in ensuring a sustainable and prudent management and use of pharmaceuticals.
Speaker Pharmacist Dr. Adela Maghear, Pharmaceuticals Policy Officer – Health Care Without Harm (HCWH) Europe Adela is a pharmacy studies graduate and holds PhD degrees in Medical Sciences (field of Pharmacy) and in Chemistry awarded by the University of Medicine and Pharmacy Cluj-Napoca (Romania) and University of Lorraine (France). Her research work and scientific publications dealt with subjects related with environmental safety. Her career in the field of health policies started with a traineeship at the European Parliament Research Service in Brussels in 2015 and continued with her becoming a member of the European Health Parliament, Antimicrobial Resistance Committee in the same year. In 2016 she has brought her skills and expertise in the fields of health and environment to HCWH Europe where she is leading the organisation’s policy work in the field of pharmaceuticals in the environment and antimicrobial resistance. About HCWH Europe
HCWH Europe is a non-profit European coalition of hospitals, healthcare systems, healthcare professionals, local authorities, research/academic institutions and environmental and health organisations. It currently has 84 members in 26 countries from the WHO European region, including 17 EU member states. HCWH Europe works to transform the healthcare sector worldwide so that it becomes more ecologically sustainable and a leading advocate for environmental health and justice across the globe. We bring the voice of healthcare professionals to the European policy debate about key issues such as chemicals, climate change and health, green building, sustainable procurement, pharmaceuticals, sustainable food and waste management.
Please register the webinar from the link as soon as possible We will have limited spots (The two session will be the same)
If you have any question please contact Yu-Lin, Tsai, Chairperson of Public Health (publichealth@ipsf.org)